Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DJTWW
2651
Trump Media & Technology Group Warrants
DJTWW
$900M
| $266K | ﹤0.01% |
83,403
| – | – |
|
|
HTB
2652
HomeTrust Bancshares
HTB
$772M
| $265K | ﹤0.01% |
+5,316
| New | +$246K |
|
2653
AtaiBeckley Inc
ATAI
$2.74B
| $265K | ﹤0.01% |
+50,249
| New | +$212K |
|
2654
CoStar Group
CSGP
$13.1B
| $265K | ﹤0.01% |
9,349
+3,023
| +48% | +$104K |
|
2655
Oric Pharmaceuticals
ORIC
$1.47B
| $262K | ﹤0.01% |
24,201
-499,589
| -95% | -$4.53M |
|
2656
CALL
Tenet Healthcare
THC
$22.6B
| $262K | ﹤0.01% |
1,400
-1,000
| -42% | -$184K |
|
2657
Camden Property Trust
CPT
$10.8B
| $261K | ﹤0.01% |
+2,280
| New | +$243K |
|
2658
Roblox
RBLX
$27.4B
| $259K | ﹤0.01% |
+4,762
| New | +$237K |
|
2659
Movado Group
MOV
$774M
| $256K | ﹤0.01% |
+6,523
| New | +$204K |
|
2660
Piper Sandler
PIPR
$5.3B
| $256K | ﹤0.01% |
3,533
-330,993
| -99% | -$26.8M |
|
2661
Prospect Capital
PSEC
$1.17B
| $254K | ﹤0.01% |
+109,969
| New | +$271K |
|
|
OPLN
2662
Openlane
OPLN
$4.08B
| $252K | ﹤0.01% |
+6,120
| New | +$214K |
|
2663
Citi Trends
CTRN
$597M
| $252K | ﹤0.01% |
4,356
-4,012
| -48% | -$192K |
|
2664
Community Trust Bancorp
CTBI
$1.39B
| $252K | ﹤0.01% |
+3,480
| New | +$232K |
|
|
BOW
2665
Bowhead Specialty Holdings
BOW
$1.1B
| $251K | ﹤0.01% |
8,384
-132,756
| -94% | -$3.45M |
|
2666
Baxter International
BAX
$13.6B
| $250K | ﹤0.01% |
+11,716
| New | +$218K |
|
2667
Intercorp Financial Services
IFS
$6.06B
| $248K | ﹤0.01% |
+4,354
| New | +$216K |
|
|
TTAM
2668
Titan America SA
TTAM
$2.8B
| $248K | ﹤0.01% |
+13,286
| New | +$218K |
|
2669
Charles River Laboratories
CRL
$14.1B
| $248K | ﹤0.01% |
1,093
-10,983
| -91% | -$1.96M |
|
2670
PUT
Danaher
DHR
$154B
| $248K | ﹤0.01% |
+1,300
| New | +$236K |
|
2671
CALL
POET Technologies
POET
$1.43B
| $247K | ﹤0.01% |
+24,000
| New | +$261K |
|
2672
Matrix Service
MTRX
$311M
| $246K | ﹤0.01% |
+17,932
| New | +$231K |
|
2673
MarketAxess Holdings
MKTX
$5.71B
| $244K | ﹤0.01% |
2,153
-2,032
| -49% | -$290K |
|
|
AEVA
2674
Aeva Technologies
AEVA
$1.27B
| $244K | ﹤0.01% |
+8,499
| New | +$167K |
|
2675
Independent Bank Corp
IBCP
$824M
| $243K | ﹤0.01% |
+6,742
| New | +$231K |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.